Spirit Of America Management Corp Gilead Sciences, Inc. Transaction History

Spirit Of America Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $178,420 - $202,510	-2,750 Reduced 47.83%	3,000 $218,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $111,072 - $121,362	-1,750 Reduced 23.33%	5,750 $396,000
Q1 2021 Apr 15, 2021	SELL	$60.0 - $68.46 $477,000 - $544,257	-7,950 Reduced 51.46%	7,500 $485,000
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $56,650 - $64,550	1,000 Added 6.92%	15,450 $900,000
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $289,360 - $336,000	4,000 Added 38.28%	14,450 $1.11 Million
Q1 2020 Apr 07, 2020	BUY	$62.63 - $80.22 $322,544 - $413,133	5,150 Added 97.17%	10,450 $781,000
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $382,183 - $452,991	5,300	5,300 $429,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Spirit Of America Management Corp, based on Form 13F filings with the SEC.

Stay updated on Spirit Of America Management Corp with notifications on news.